glp 1 and chronic kidney disease Design discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis Antiinflammatory actions of GLP-1 medicines

*These findings show an association between stopping GLP-1 RAs and these outcomes, but not a causation

Back UCL (5 Feb 2025) 'GLP-1 drug shows little benefit for people with Parkinson's disease'

GLP-1 Medications: The New Weight Loss Trend Among Celebrities Jan 17, 2025 2 min read GLP-1 medications have been making waves in the world of weight loss, with celebrities like Kim Kardashian, Elon Musk, and other influencers openly sharing their positive results

Several mechanisms explain why GLP-1 RAs reduce body weight: Central appetite suppression: GLP-1 receptors in the hypothalamus and brainstem alter hunger signalling and food reward

These drugs work by mimicking the action of the naturally occurring GLP-1 hormone, which stimulates insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety

And before I tell you the first way that they might help, I need you to understand something that most people are never told, and that is